医药生物行业跟踪周报:2025ESMO中国之声闪耀全球 PD1双抗与ADC成为全球焦点

东吴证券
Oct 26, 2025

本周、年初至今A 股医药指数涨幅分别为0.58%、19.54%,相对沪深300 的超额收益分别为-2.67%、1.09%;本周、年初至今恒生生物科技指数涨跌幅分别为-1.05%、81.15%,相对于恒生科技指数跑赢5.22%、36.90%;本周医疗服务(+3.94%)、医药商业(+2.27%)、医药器械(+0.89%)、原料药(+0.25%)股价有所上涨;化学制药(-0.31%)、生物制品(-...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10